Monoamine metablites as predictors of anttoepressant response: A critique

Aberg-Wistedt, 1981, Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression, Psychopharmacology (Berlin), 74, 297, 10.1007/BF00432735 Aberg-Wistedt, 1982, A double blind study of zimelidine a serotonin reuptake inhibitor and desipramine, a noradrenaline reuptake inhibitor in endogenous depression. II. Biochemical finding, Acta. Psychiatr. Scand., 66, 66, 10.1111/j.1600-0447.1982.tb00915.x Agren, 1982, Depressive symptom patterns and urinary MHPG excretion, Psychiatry Res., 6, 185, 10.1016/0165-1781(82)90006-3 Aizenstein, 1979, On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine, J. Neurochem., 32, 1227, 10.1111/j.1471-4159.1979.tb11050.x Alonso, 1982, Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans, Biol. Psychiatry, 17, 781 Asberg, 1973, Indoleamine metabolites in cerebrospinal fluid of depressed patients before and during treatment with nortriptyline, Clin. Pharmacol. Ther., 14, 277, 10.1002/cpt1973142277 Asberg, 1975, Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine, Clin. Pharmacol. Ther., 21, 201, 10.1002/cpt1977212201 Banki, 1977, Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women, J. Neural. Transm., 41, 135, 10.1007/BF01670278 Banki, 1981, Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes, Psychiatry Res., 5, 23, 10.1016/0165-1781(81)90057-3 Banki, 1981, Cerebrospinal fluid amine metabolites tryptophan and clinical parameters in depression, Part I, background variables, J. Affective Disord., 3, 81, 10.1016/0165-0327(81)90033-1 Beckmann, 1975, Antidepressant response to tricyclics and urinary MHPG in unipolar patients, Arch. Gen. Psychiatry, 32, 17, 10.1001/archpsyc.1975.01760190019001 Beckmann, 1977, Phenelzine in depressed patients, Neuropsychobiology, 3, 49, 10.1159/000117589 Beckmann, 1980, Urinary MHPG in subgroups of depressed patients and normal control, Neuropsychobiology, 6, 91, 10.1159/000117740 Blombery, 1980, Conversion of MHPG to vanillylmandelic acid, Arch. Gen. Psychiatry, 37, 1095, 10.1001/archpsyc.1980.01780230013001 Charney, 1981, Plasma MHPG in depression: Effects of acute and chronic desipramine treatment, Psychiatry Res., 5, 217, 10.1016/0165-1781(81)90051-2 Charney, 1982, Assessment of alpha2 adrenergic autoreceptor function in humans: Effects of oral yohimbine, Life Sci., 30, 2033, 10.1016/0024-3205(82)90444-1 Chase, 1973, Norepinephrine metabolism in the central nervous system of man: Studies using 3-methyoxy-4-hydroxypheny1ethylene glycol levels in CSF, J. Neurochem., 21, 581, 10.1111/j.1471-4159.1973.tb06003.x Cobbin, 1979, Urinary MHPG levels and tricyclic antidepressant drug selection, Arch. Gen. Psychiatry, 36, 1111, 10.1001/archpsyc.1979.01780100081007 Coppen, 1979, Urinary 4-hydroxy-3-methoxypheny1glycol is not a predictor for clinical response to amitriptyline in depressive illness, Psychopharmacology (Berlin), 64, 95, 10.1007/BF00427352 Curzon, 1971, Amine metabolites in the lumbar CSF of humans with restricted flow of cerebrospinal fluid, Nature, 231, 189 Curzon, 1972, Effect of immobilization and food deprivation on rat brain tryptophan metabolism, J. Neurochem., 19, 1967, 10.1111/j.1471-4159.1972.tb01486.x Curzon, 1980, Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular CSF of psychiatric patients, Acta Psychiatr. Scand. (Suppl.), 280, 3, 10.1111/acps.1980.61.s280.3 Ebert, 1972, Effect of physical activity on urinary MHPG excretion in depressed patients, Lancet, II, 766, 10.1016/S0140-6736(72)92064-8 Ellsworth, 1982, Plasma and cerebrospinal fluid 3-methoxy-4 hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates, Brain Res., 235, 115, 10.1016/0006-8993(82)90200-1 Frankenhaeuser, 1971, Behavior and circulating catecholamines, Brain Res., 31, 241, 10.1016/0006-8993(71)90180-6 Gaertner, 1982, Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?, Psychopharmacology, 76, 236, 10.1007/BF00432552 Gerner, 1979, Biological and behavioral effects of one nights sleep deprivation in depressed patients and normals, J. Psychiatr. Res., 15, 21, 10.1016/0022-3956(79)90004-9 Goodwin, 1973, Cerebrospinal fluid amine metabolites and therapies for depression, 126, 24 Goran, 1981, Norepinephrine metabolism in man using duetrium labelling: The conversion of 4-hydroxy-3-methoxyphenylglycol to 4-hydroxy-3-methoxymandelic acid, J. Neurochem., 36, 1181, 10.1111/j.1471-4159.1981.tb01716.x Gottfries, 1969, Homovanillic acid and 5 hydroxyindoleacetic acid in the CSF of patients with senile dementia presenile dementia and parkinsonism, J. Neurochem., 16, 1341, 10.1111/j.1471-4159.1969.tb05984.x Greenspan, 1970, Catecholamine metabolism in affective disorders, J. Psychiatr. Res., 7, 171, 10.1016/0022-3956(70)90004-X Halaris, 1979, Studies of norepinephrine metabolism in manic and depressive states Hollister, 1980, Subtypes of depression based on excretion of MHPG and response to nortriptyline, Arch. Gen. Psychiatry, 37, 1107, 10.1001/archpsyc.1980.01780230025003 Hollister, 1980, Asthma and alcohol withdrawal as sources of artifact in urinary excretion of 3-methoxy-4-hydroxy1 phenylglycol (MHPG), Commun. Psychopharmacol., 4, 135 Hollister, 1981, Excretion of 3-methoxy-4-hydroxyphenylglycol in depressed and geriatric patients and normal persons, Int. Pharmacopsychiatry, 16, 138, 10.1159/000468488 Jimerson, 1981, Plasma and CSF MHPG in normals, Psychopharmacol. Bull., 17, 86 Kessler, 1976, 3-methoxy-4-hydroxypheny1ethylqlycol (MHPG) transport from the spinal cord during subarachnoid perfusion, Brain Res., 102, 131, 10.1016/0006-8993(76)90579-5 La Brosse, 1970, Catecholamine metabolism in neuroblastoma: Kinetics of conversion of 3H-3 methoxy-4-hydroxyphenylglycol to 3H-3-(nethoxy-4-hydroxymande lic acid, J. Clin. Endocrinol. Metab., 30, 580, 10.1210/jcem-30-5-580 Linnoila, 1982, High correlation of norepinephrine and its major metabolite excretion rates, Arch. Gen. Psychiatry, 39, 521, 10.1001/archpsyc.1982.04290050011003 Maas, 1968, In vivo studies of metabolism of norepinephrine in central nervous system, J. Pharmacol. Exp. Ther., 163, 147 Maas, 1968, 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depressive states A pilot study, Arch. Gen. Psychiatry, 19, 129, 10.1001/archpsyc.1968.01740080001001 Maas, 1971, Catecholamine metabolism, depression and stress, Nature, 23, 330, 10.1038/230330a0 Maas, 1972, Catecholamine metabolism depressive illness and drug response, Arch. Gen. Psychiatry, 26, 252, 10.1001/archpsyc.1972.01750210060012 Maas, 1974, MHPG excretion by patients with affective disorders, Int. Pharmacopsychiatry, 9, 14, 10.1159/000468112 Maas, 1975, Biogenic amines and depression, Arch. Gen. Psychiatry, 32, 1357, 10.1001/archpsyc.1975.01760290025002 Maas, 1977, A direct method for studying 3-methoxy-4-hydroxy-phenethylene-glycol (MHPG) production by brain in awake animals, Eur. J. Pharmacol., 46, 221, 10.1016/0014-2999(77)90337-5 Maas, 1979, 3-methoxy-4-hydroxyphenethyleneglycol production in human brain in vivo, Science, 205, 1025, 10.1126/science.472724 Mathew, 1981, Depression antidepressants and plasma DBH, Psychiatry Res., 5, 331, 10.1016/0165-1781(81)90080-9 Modai, 1979, Response to amitriptyline and urinary MHPG in bipolar depressed patients, Neuropsychobiology, 5, 131, 10.1159/000117681 Muscettola, 1981, Methodologial issues in the measurement of urinary MHPG, Psychiatry Res., 4, 267, 10.1016/0165-1781(81)90028-7 Ogata, 1971, Adrenal function in alcoholism. II, Catecholamines. Psychosom. Med., 33, 159, 10.1097/00006842-197103000-00007 Perry, 1978, Clinical study of mianserin imipramine and placebo in depression. Blood levels and MHPG correlation, Br. J. Clin. Pharmacol., 5, 355, 10.1111/j.1365-2125.1978.tb04573.x Post, 1973, Psychomotor activity and CSF amine metabolites in affective illness, Am. J. Psychiatry, 130, 67, 10.1176/ajp.130.1.67 Post, 1978, Effects of dopamine aaonist peribedil in depressed patients, Arch. Gen. Psychiatry, 78, 609, 10.1001/archpsyc.1978.01770290091008 Post, 1978, Approaches to brain amines in psychiatric patients. A reevaluation of cerebrospinal fluid studies, Handbook of Psychopharmacology, 13, 147, 10.1007/978-1-4684-3189-6_3 Robinson, 1978, Clinical pharmacology of phenelzine, Arch. Gen. Psychiatry, 35, 629, 10.1001/archpsyc.1978.01770290111010 Roccatagliata, 1981, CSF-MHPG in depressive syndromes: Basal values and imipramine induced modifications, Neuropsychobiology, 7, 169, 10.1159/000117846 Rosenbaum, 1980, MHPG as a predictor of antidepressant response to imiprannne and maprotiline, Am. J. Psychiatry, 137, 1090, 10.1176/ajp.137.9.1090 Rosloff, 1974, Effects of iprindole on norepinephrine turnover and transport, Psychopharmacology (Berlin), 40, 53, 10.1007/BF00429447 Rubin, 1970, The stress of aircraft landings. II. 3-methoxy-4-hydroxypheny1g1ycol excretion in naval aviators, Psychosom. Med., 32, 489, 10.1097/00006842-197011000-00004 Sachetti, 1976, MHPG amitriptyline and affective disorders. A longitudinal study, Int. Pharmacopsychiatry, 11, 157, 10.1159/000468225 Sachetti, 1979, 3-methoxy-4-hydroxyphenylglycol and primary depression: Clinical and pharmacological considerations, Biol. Psychiatry, 14, 473 Schatzberg, 1980, Toward a biochemical classification of depressive disorders. IV. Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine, Commun. Psychopharmacol., 4, 441 Schatzberg, 1981, Toward a biochemical classification of depressive disorders. III. Preatment of urinary MHPG levels as predictors of response to treatment with maprotiline, Psychopharmacology (Berlin), 75, 34, 10.1007/BF00433498 Shaw, 1973, MHPG in derpession, Psychol. Med., 3, 333, 10.1017/S003329170004962X Schildkraut, 1973, Norepinehrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: Preliminary findings, Am. J. Psychiatry, 130, 695, 10.1176/ajp.130.6.695 Schildkraut, 1973, MHPG excretion and clinical classification in depressive disorders, Lancet, I, 1251, 10.1016/S0140-6736(73)90567-9 Schildkraut, 1974, Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: Preliminary findings from studies of norepinephrine metabolism, Pharmakopsychiat. Neuropsychopharmakol., 7, 98, 10.1055/s-0028-1094408 Schildkraut, 1978, Towards a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depression, Arch. Gen. Psychiatry, 35, 1427, 10.1001/archpsyc.1978.01770360031003 Schildkraut, 1978, Toward a biochemical classification of depressive disorders II, Arch. Gen. Psychiatry, 35, 1436, 10.1001/archpsyc.1978.01770360040004 Shopsin, 1973, Collaborative psychopharmacological studies exploring catecholamine metabolism in psychiatric disorders Shopsin, 1974, Catecholamines and affective disorders revised. A critical assessment, J. Nerv. Ment. Dis., 158, 369, 10.1097/00005053-197405000-00008 Siever, 1982, Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls, Psychiatry Res., 6, 171, 10.1016/0165-1781(82)90005-1 Siwers, 1977, Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients, Clin. Pharmacol. Ther., 21, 194, 10.1002/cpt1977212194 Sjostrom, 1975, Concentration gradients of monoamine metabolites in human cerebrospinal fluid, J. Neurol. Neurosurg. & Psychiatry, 38, 666, 10.1136/jnnp.38.7.666 Sourkes, 1973, On the origin of HVA in the cerebrospinal fluid, J. Neural. Transm., 34, 153, 10.1007/BF01244668 Spiker, 1980, Urinary MHPG and clinical response to amitriptyline in depressed patients, Am. J. Psychiatry, 137, 1183, 10.1176/ajp.137.10.1183 Tang, 1978, A radioactive method for the measurement of central nervous system catecholamine in vivo, Can. J. Physiol. Pharmacol, 56, 535, 10.1139/y78-085 Tang, 1981, Controlled exercise elevates plasma but not urinary MHPG and VMA, Psychiatry Res., 4, 13, 10.1016/0165-1781(81)90003-2 Van Praag, 1977, New evidence of serotonin deficient depressions, Neuropsychobiology, 3, 56, 10.1159/000117590 Van Praag, 1980, Depression vulnerability and 5-hydroxytyryptophan prophylaxis, Psychiatry Res., 3, 75, 10.1016/0165-1781(80)90049-9 Van Praag, 1981, Central monoamines in the pathogenesis of depression, IV Van Scheyen, 1977, Controlled study comparing nomifensine and chlorimipramine in unipolar depression using the probenicid technique, Br. J. Clin. Pharmacol., 4, 179, 10.1111/j.1365-2125.1977.tb05749.x Wehr, 1980, Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects, Arch. Gen. Psychiatry, 37, 257, 10.1001/archpsyc.1980.01780160027002